Filing Details

Accession Number:
0001209191-21-063270
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-05 19:41:15
Reporting Period:
2021-11-03
Accepted Time:
2021-11-05 19:41:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1020214 Cerus Corp CERS Surgical & Medical Instruments & Apparatus (3841) 680262011
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296322 J Richard Benjamin C/O Cerus Corporation
1220 Concord Ave Suite 600
Concord CA 94505
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-03 100,000 $4.72 176,035 No 4 M Direct
Common Stock Disposition 2021-11-03 100,000 $7.90 76,035 No 4 S Direct
Common Stock Acquisiton 2021-11-03 33,333 $4.33 109,368 No 4 M Direct
Common Stock Disposition 2021-11-03 33,333 $7.35 76,035 No 4 S Direct
Common Stock Acquisiton 2021-11-03 31,667 $4.32 107,702 No 4 M Direct
Common Stock Disposition 2021-11-03 31,667 $7.35 76,035 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2021-11-03 100,000 $0.00 100,000 $4.72
Common Stock Option (Right to Buy) Disposition 2021-11-03 33,333 $0.00 33,333 $4.33
Common Stock Option (Right to Buy) Disposition 2021-11-03 31,667 $0.00 31,667 $4.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-08-31 No 4 M Direct
8,334 2027-02-28 No 4 M Direct
31,667 2028-02-28 No 4 M Direct
Footnotes
  1. This transaction was executed pursuant to a 10b5-1 plan.
  2. One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.
  3. Not applicable.